Haemostatic Effects of Stress

  • Paul HjemdahlEmail author
  • Roland von Känel


The three major components of haemostasis – platelet activation, blood coagulation and fibrinolysis – are finely tuned to maintain flowing blood in the normal blood vessel, and yet stop bleeding and repair wounds when vessels are damaged. When the system is perturbed, arterial thrombosis may cause myocardial infarction (MI), stroke and other acute ischaemic events. Acute coronary events are often caused by atherosclerotic plaque rupture triggered by haemodynamic factors that increase wall stress and inflammatory weakening of the fibrous cap that covers the plaque.


Haemostatic effects Pro-thrombotic mechanisms Anti-thrombotic mechanisms Platelets Blood coagulation Fibrinolysis Methodology Biomarkers Vital exhaustion 


  1. 1.
    Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis. JACC. 2009;54:2129-2138.PubMedCrossRefGoogle Scholar
  2. 2.
    Huo Y, Schober A, Bradley Forlow S, et al. Circulating activated platelets exacerbate ­atherosclerosis in mice deficient in apolipoprotein E. Nat Med. 2003;9:61-67.PubMedCrossRefGoogle Scholar
  3. 3.
    Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest. 2005;115:3378-3384.PubMedCrossRefGoogle Scholar
  4. 4.
    Langer HF, Bigalke B, Seizer P, et al. Interaction of platelets and inflammatory endothelium in the development and progression of coronary artery disease. Semin Thromb Hemost. 2010;36:131-138.PubMedCrossRefGoogle Scholar
  5. 5.
    Michelson AD, ed. Platelets. 2nd ed. San Diego: Academic; 2007.Google Scholar
  6. 6.
    Deanfield JE, Halcox JP, Rabelink JP. Endothelial function and dysfunction: testing and ­clinical relevance. Circulation. 2007;115:1285-1295.PubMedGoogle Scholar
  7. 7.
    Antman EM, Bennett JS, Daugherty A, et al. Use of nonsteroidal antiinflammatory drugs – an update for clinicians; a scientific statement from the American Heart Association. Circulation. 2007;115:1634-1642.PubMedCrossRefGoogle Scholar
  8. 8.
    von Känel R, Mills PJ, Fainman C, Dimsdale JE. Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease? Psychosom Med. 2001;63:531-544.Google Scholar
  9. 9.
    Angiolillo DJ, Capodanno D, Goto S. Platelet thrombin receptor antagonism and atherothrombosis. Eur Heart J. 2010;31:17-28.PubMedCrossRefGoogle Scholar
  10. 10.
    Harrrison P, Frelinger AL, Furman MI, Michelson AD. Measuring antiplatelet drug effects in the laboratory. Thromb Res. 2007;120:323-336.CrossRefGoogle Scholar
  11. 11.
    Cattaneo M. Resistance to antiplatelet drugs: molecular mechanisms and laboratory detection. J Thromb Haemost. 2007;5(suppl 1):230-237.PubMedCrossRefGoogle Scholar
  12. 12.
    Li N, Goodall AH, Hjemdahl P. A sensitive flow cytometric assay for circulating platelet-­leukocyte aggregates. Br J Haematol. 1997;99:808-816.PubMedCrossRefGoogle Scholar
  13. 13.
    Li N, Goodall A, Hjemdahl P. Efficient flow cytometric assay for platelet-leukocyte aggregates in whole blood using fluorescence signal triggering. Cytometry. 1999;35:154-161.PubMedCrossRefGoogle Scholar
  14. 14.
    Beck O, Wallén NH, Bröijersén A, et al. On the accurate determination of serotonin in human plasma. Biochem Biophys Res Commun. 1993;196:260-266.PubMedCrossRefGoogle Scholar
  15. 15.
    Patrono C, Garcia Rodriguez LA, Landolfi R, Baigent C. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med. 2005;353:2373-2383.PubMedCrossRefGoogle Scholar
  16. 16.
    von Känel R, Preckel D, Zgraggen L, et al. The effect of natural habituation on coagulation responses to acute mental stress and recovery in men. Thromb Haemost. 2004;92:1327-1335.Google Scholar
  17. 17.
    Wiman B, Hamsten A. Impaired fibrinolysis and risk of thromboembolism. Prog Cardiovasc Dis. 1991;34:179-192.PubMedCrossRefGoogle Scholar
  18. 18.
    Herren T, Stricker H, Haeberli A, et al. Fibrin formation and degradation in patients with ­arteriosclerotic disease. Circulation. 1994;90:2679-2686.PubMedCrossRefGoogle Scholar
  19. 19.
    Allen MT, Patterson SM. Hemoconcentration and stress: a review of physiological mechanisms and relevance for cardiovascular disease risk. Biol Psychol. 1995;41:1-27.PubMedCrossRefGoogle Scholar
  20. 20.
    Bacon SL, Ring C, Lip GY, Carroll D. Increases in lipids and immune cells in response to exercise and mental stress in patients with suspected coronary artery disease: effects of adjustment for shifts in plasma volume. Biol Psychol. 2004;65:237-250.PubMedCrossRefGoogle Scholar
  21. 21.
    von Känel R, Kudielka BM, Haeberli A, et al. Prothrombotic changes with acute psychological stress: combined effect of hemoconcentration and genuine coagulation activation. Thromb Res. 2009;123:622-630.CrossRefGoogle Scholar
  22. 22.
    von Känel R, Preckel D, Kudielka BM, Fischer JE. Responsiveness and habituation of soluble ICAM-1 to acute psychosocial stress in men: determinants and effect of stress-hemoconcentration. Physiol Res. 2007;56:627-639.Google Scholar
  23. 23.
    Hjemdahl P, Larsson PT, Wallén H. Effects of stress and ß-blockade on platelet function. Circulation. 1991;84(suppl 6):VI-44-VI-61.Google Scholar
  24. 24.
    von Känel R, Dimsdale JE. Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur J Haematol. 2000;65:357-369.CrossRefGoogle Scholar
  25. 25.
    Preckel D, von Känel R. Regulation of hemostasis by the sympathetic nervous system: any contribution to coronary artery disease? Heartdrug. 2004;4:123-130.PubMedGoogle Scholar
  26. 26.
    Brydon L, Magid K, Steptoe A. Platelets, coronary heart disease, and stress. Brain Behav Immun. 2005;20:113-119.PubMedCrossRefGoogle Scholar
  27. 27.
    Thrall G, Lane D, Carroll D, Lip GYH. A systematic review of the effects of acute ­psychological stress and physical activity on haemorheology, coagulation, fibrinolysis and platelet ­reactivity: implications for the pathogenesis of acute coronary syndromes. Thromb Res. 2007;120:819-847.PubMedCrossRefGoogle Scholar
  28. 28.
    Larsson PT, Hjemdahl P, Olsson G, et al. Platelet aggregability: contrasting in vivo and in vitro findings during sympatho-adrenal activation and relationship to serum lipids. Eur J Clin Invest. 1990;20:398-405.PubMedCrossRefGoogle Scholar
  29. 29.
    Larsson PT, Wallén NH, Egberg N, Hjemdahl P. α-Adrenoceptor blockade by phentolamine inhibits adrenaline-induced platelet activation in vivo without affecting resting measurements. Clin Sci. 1992;82:369-376.PubMedGoogle Scholar
  30. 30.
    Larsson PT, Olsson G, Angelin B, et al. Metoprolol does not reduce platelet aggregability ­during sympatho-adrenal stimulation. Eur J Clin Pharmacol. 1992;42:413-421.PubMedGoogle Scholar
  31. 31.
    Larsson PT, Wallén NH, Martinsson A, et al. Significance of platelet ß-adrenoceptors for ­platelet responses in vivo and in vitro. Thromb Haemost. 1992;68:687-693.PubMedGoogle Scholar
  32. 32.
    Larsson PT, Wallén NH, Hjemdahl P. Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. Circulation. 1994;89:1951-1957.PubMedCrossRefGoogle Scholar
  33. 33.
    Hjemdahl P, Chronos N, Wilson D, et al. Epinephrine sensitizes human platelets in vivo and in vitro as studied by fibrinogen binding and P-selectin expression. Arterioscler Thromb. 1994;14:77-84.PubMedCrossRefGoogle Scholar
  34. 34.
    Li N, Wallén NH, Hjemdahl P. Evidence for prothrombotic effects of exercise and limited protection by aspirin. Circulation. 1999;100:1374-1379.PubMedCrossRefGoogle Scholar
  35. 35.
    Ikarugi H, Taka T, Nakajima S, et al. Norepinephrine, but not epinephrine, enhances platelet reactivity and coagulation after exercise in humans. J Appl Physiol. 1999;86:133-138.PubMedGoogle Scholar
  36. 36.
    Larsson PT, Wiman B, Olsson G, et al. Influence of metoprolol treatment on sympatho-adrenal activation of fibrinolysis. Thromb Haemost. 1990;63:482-487.PubMedGoogle Scholar
  37. 37.
    von Känel R, Dimsdale JE, Adler KA, et al. Effects of nonspecific beta-adrenergic stimulation and blockade on blood coagulation in hypertension. J Appl Physiol. 2003;94:1455-1459.Google Scholar
  38. 38.
    von Känel R, Mills PJ, Ziegler MG, Dimsdale JE. Effect of beta2-adrenergic receptor functioning and increased norepinephrine on the hypercoagulable state with mental stress. Am Heart J. 2002;144:68-72.CrossRefGoogle Scholar
  39. 39.
    Wirtz PH, Ehlert U, Emini L, et al. Anticipatory cognitive stress appraisal and the acute ­procoagulant stress response in men. Psychosom Med. 2006;68:851-858.PubMedCrossRefGoogle Scholar
  40. 40.
    von Känel R, Kudielka BM, Abd-el-Razik A, et al. Relationship between overnight neuroendocrine activity and morning haemostasis in working men. Clin Sci (Lond). 2004;107:89-95.CrossRefGoogle Scholar
  41. 41.
    von Känel R, Mausbach BT, Kudielka BM, Orth-Gomér K. Relation of morning serum cortisol to prothrombotic activity in women with stable coronary artery disease. J Thromb Thrombolysis. 2008;25:165-172.CrossRefGoogle Scholar
  42. 42.
    Lippi G, Franchini M, Salvagno GL, et al. Higher morning serum cortisol level predicts increased fibrinogen but not shortened APTT. J Thromb Thrombolysis. 2008;26:103-105.PubMedCrossRefGoogle Scholar
  43. 43.
    von Känel R, Nelesen RA, Ziegler MG, et al. Relation of autonomic activity to plasminogen activator inhibitor-1 plasma concentration and the role of body mass index. Blood Coagul Fibrinolysis. 2007;18:353-359.CrossRefGoogle Scholar
  44. 44.
    von Känel R, Orth-Gomér K. Autonomic function and prothrombotic activity in women after an acute coronary event. J Womens Health (Larchmt). 2008;17:1331-1337.CrossRefGoogle Scholar
  45. 45.
    von Känel R, Thayer JF, Fischer JF. Night-time vagal cardiac control and plasma fibrinogen levels in a population of working men and women. Ann Noninvasive Electrocardiol. 2009;14:176-184.CrossRefGoogle Scholar
  46. 46.
    Jae SY, Carnethon MR, Ahn ES, et al. Association between heart rate recovery after exercise testing and plasminogen activator inhibitor 1, tissue plasminogen activator, and fibrinogen in apparently healthy men. Atherosclerosis. 2008;197:415-419.PubMedCrossRefGoogle Scholar
  47. 47.
    Wallén NH, Goodall AH, Li N, Hjemdahl P. Activation of hemostasis by exercise, mental stress and epinephrine; effects on platelet sensitivity to thrombin and thrombin generation. Clin Sci. 1999;97:27-35.PubMedCrossRefGoogle Scholar
  48. 48.
    Wallén NH, Held C, Rehnqvist N, Hjemdahl P. Effects of mental and physical stress on platelet function in patients with stable angina pectoris and healthy controls. Eur Heart J. 1997;18:807-815.PubMedCrossRefGoogle Scholar
  49. 49.
    Grignani G, Pacchiarini L, Zucchella M, et al. Effect of mental stress on platelet function in normal subjects and in patients with coronary artery disease. Haemostasis. 1992;22:138-146.PubMedGoogle Scholar
  50. 50.
    Reid GJ, Seidelin PH, Kop WJ, et al. Mental stress-induced platelet activation among patients with coronary artery disease. Psychosom Med. 2009;71:438-445.PubMedCrossRefGoogle Scholar
  51. 51.
    Aschbacher K, Mills PJ, von Känel R, et al. Effects of depressive and anxious symptoms on norepinephrine and platelet P-selectin responses to acute psychological stress among elderly caregivers. Brain Behav Immun. 2008;22:493-502.PubMedCrossRefGoogle Scholar
  52. 52.
    Steptoe A, Magid K, Edwards S, et al. The influence of psychological stress and ­socioeconomic status on platelet activation in men. Atherosclerosis. 2003;168:57-63.PubMedCrossRefGoogle Scholar
  53. 53.
    Strike PC, Magid K, Brydon L, et al. Exaggerated platelet and hemodynamic reactivity to mental stress in men with coronary artery disease. Psychosom Med. 2004;66:492-500.PubMedCrossRefGoogle Scholar
  54. 54.
    Wang J-S. Intense exercise increases shear-induced platelet aggregation in men through enhancement of von Willebrand factor binding, glycoprotein IIb/IIIa activation, and P-selectin expression on platelets. Eur J Appl Physiol. 2004;91:741-747.PubMedCrossRefGoogle Scholar
  55. 55.
    Aurigemma C, Fattorossi A, Sestito A, et al. Relationship between changes in platelet reactivity and changes in platelet receptor expression induced by physical exercise. Thromb Res. 2007;120:901-909.PubMedCrossRefGoogle Scholar
  56. 56.
    Wang J-S, Liao C-H. Moderate-intensity exercise suppresses platelet activation and polymorphonuclear leukocyte interaction with surface-adherent platelets under shear flow in men. Thromb Haemost. 2004;91:587-594.PubMedGoogle Scholar
  57. 57.
    Wang J-S, Li Y-S, Chen J-C, Chen Y-W. Effects of exercise training and deconditioning on platelet aggregation induced by alternating shear stress in men. Arterioscler Thromb Vasc Biol. 2005;25:454-460.PubMedCrossRefGoogle Scholar
  58. 58.
    Lippi G, Mafulli N. Biological influence of physical exercise on hemostasis. Semin Thromb Hemost. 2009;35:269-276.PubMedCrossRefGoogle Scholar
  59. 59.
    Wang J-S, Li Y-S, Yang C-M. Warm-up exercise suppresses platelet-eosinofi/neutrophil aggregation and platelet-promoted release of eosinofi/neutrophil oxidant products enhanced by severe exercise in men. Thromb Haemost. 2006;95:490-498.PubMedGoogle Scholar
  60. 60.
    Perneby C, Wallén NH, Hu H, et al. Prothrombotic responses to exercise are little influenced by clopidogrel treatment. Thromb Res. 2004;114:135-143.CrossRefGoogle Scholar
  61. 61.
    Perneby C, Hofman-Bang C, Wallén NH, et al. Effect of clopidogrel treatment on ­stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease. Thromb Haemost. 2007;98:1316-1322.PubMedGoogle Scholar
  62. 62.
    Li N, He S, Blombäck M, Hjemdahl P. Platelet activity, coagulation, and fibrinolysis during exercise in healthy males: effects of thrombin inhibition by argatroban and enoxaparin. Arterioscler Thromb Vasc Biol. 2007;27:407-412.PubMedCrossRefGoogle Scholar
  63. 63.
    Wallén NH, Held C, Rehnqvist N, Hjemdahl P. Platelet aggregability in vivo is attenuated by verapamil but not by metoprolol in patients with stable angina pectoris. Am J Cardiol. 1995;75:1-6.PubMedCrossRefGoogle Scholar
  64. 64.
    Jern C, Eriksson E, Tengborn L, et al. Changes of plasma coagulation and fibrinolysis in response to mental stress. Thromb Haemost. 1989;62:767-771.PubMedGoogle Scholar
  65. 65.
    Jern C, Manhem K, Eriksson E, et al. Hemostatic response to mental stress during the ­menstrual cycle. Thromb Haemost. 1991;66:614-618.PubMedGoogle Scholar
  66. 66.
    Jern C, Selin L, Jern S. In vivo release of tissue-type plasminogen activator across the human forearm during mental stress. Thromb Haemost. 1994;72:285-291.PubMedGoogle Scholar
  67. 67.
    Wirtz PH, Redwine LS, Baertschi C, et al. Coagulation activity before and after acute psychosocial stress increases with age. Psychosom Med. 2008;70:476-481.PubMedCrossRefGoogle Scholar
  68. 68.
    Palermo A, Bertalero P, Pizza N, et al. Decreased fibrinolytic response to adrenergic stimulation in hypertensive patients. J Hypertens. 1989;7(suppl):S162-S163.Google Scholar
  69. 69.
    Held C, Hjemdahl P, Rehnqvist N, et al. Prognostic implications of fibrinolytic variables in patients with stable angina pectoris treated with verapamil or metoprolol. Results from the APSIS study. Circulation. 1997;95:2380-2386.PubMedCrossRefGoogle Scholar
  70. 70.
    von Känel R, Dimsdale JE, Ziegler MG, et al. Effect of acute psychological stress on the hypercoagulable state in subjects (spousal caregivers of patients with Alzheimer’s disease) with coronary or cerebrovascular disease and/or systemic hypertension. Am J Cardiol. 2001;87:1405-1408.CrossRefGoogle Scholar
  71. 71.
    Canevari A, Tacconi F, Zucchella M, et al. Antithrombin III biological activity and emotional stress in patients with coronary artery disease. Haematologica. 1992;77:180-182.PubMedGoogle Scholar
  72. 72.
    von Känel R, Dimsdale JE, Patterson TL, Grant I. Acute procoagulant stress response as a dynamic measure of allostatic load in Alzheimer caregivers. Ann Behav Med. 2003;26:42-48.CrossRefGoogle Scholar
  73. 73.
    Aschbacher K, von Känel R, Dimsdale JE, et al. Dementia severity of the care receiver predicts procoagulant response in Alzheimer caregivers. Am J Geriatr Psychiatry. 2006;14:694-703.PubMedCrossRefGoogle Scholar
  74. 74.
    von Känel R, Dimsdale JE, Adler KA, et al. Effects of depressive symptoms and anxiety on hemostatic responses to acute mental stress and recovery in the elderly. Psychiatry Res. 2004;126:253-264.CrossRefGoogle Scholar
  75. 75.
    Markovitz JH, Matthews KA, Kiss J, Smitherman TC. Effects of hostility on platelet reactivity to psychological stress in coronary heart disease patients and in healthy controls. Psychosom Med. 1996;58:143-149.PubMedGoogle Scholar
  76. 76.
    Markovitz JH. Hostility is associated with increased platelet activation in coronary heart ­disease. Psychosom Med. 1998;60:586-591.PubMedGoogle Scholar
  77. 77.
    Steptoe A, Wardle J, Marmot M. Positive affect and health-related neuroendocrine, cardiovascular, and inflammatory processes. Proc Natl Acad Sci USA. 2005;102:6508-6512.PubMedCrossRefGoogle Scholar
  78. 78.
    Wirtz PH, Redwine LS, Ehlert U, von Känel R. Independent association between lower level of social support and higher coagulation activity before and after acute psychosocial stress. Psychosom Med. 2009;71:30-37.PubMedCrossRefGoogle Scholar
  79. 79.
    von Känel R. Psychological distress and cardiovascular risk: what are the links? J Am Coll Cardiol. 2008;52:2163-2165.CrossRefGoogle Scholar
  80. 80.
    Kaptoge S, White IR, Thompson SG, et al. Fibrinogen Studies Collaboration: associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies: the fibrinogen studies collaboration. Am J Epidemiol. 2007;166:867-879.PubMedCrossRefGoogle Scholar
  81. 81.
    Kittel F, Leynen F, Stam M, et al. Job conditions and fibrinogen in 14226 Belgian workers: the Belstress study. Eur Heart J. 2002;23:1841-1848.PubMedCrossRefGoogle Scholar
  82. 82.
    Theorell T. Job stress and fibrinogen. Eur Heart J. 2002;23:1799-1801.PubMedCrossRefGoogle Scholar
  83. 83.
    Frimerman A, Miller HI, Laniado S, Keren G. Changes in hemostatic function at times of cyclic variation in occupational stress. Am J Cardiol. 1997;79:72-75.PubMedCrossRefGoogle Scholar
  84. 84.
    von Känel R, Dimsdale JE, Mills PJ, et al. Effect of Alzheimer caregiving stress and age on frailty markers interleukin-6, C-reactive protein, and D-dimer. J Gerontol A Biol Sci Med Sci. 2006;61:963-969.CrossRefGoogle Scholar
  85. 85.
    von Känel R, Dimsdale JE, Ancoli-Israel S, et al. Poor sleep is associated with higher plasma proinflammatory cytokine interleukin-6 and procoagulant marker fibrin D-dimer in older caregivers of people with Alzheimer’s disease. J Am Geriatr Soc. 2006;54:431-437.CrossRefGoogle Scholar
  86. 86.
    Mausbach BT, Ancoli-Israel S, von Känel R, et al. Sleep disturbance, norepinephrine, and D-dimer are all related in elderly caregivers of people with Alzheimer disease. Sleep. 2006;29:1347-1352.PubMedGoogle Scholar
  87. 87.
    Mausbach BT, Aschbacher K, Patterson TL, et al. Effects of placement and bereavement on psychological well-being and cardiovascular risk in Alzheimer’s caregivers: a longitudinal analysis. J Psychosom Res. 2007;62:439-445.PubMedCrossRefGoogle Scholar
  88. 88.
    Mausbach BT, von Känel R, Aschbacher K, et al. Spousal caregivers of patients with Alzheimer’s disease show longitudinal increases in plasma level of tissue-type plasminogen activator antigen. Psychosom Med. 2007;69:816-822.PubMedCrossRefGoogle Scholar
  89. 89.
    Halperin D, Reber G. Influence of antidepressants on hemostasis. Dialogues Clin Neurosci. 2007;9:47-59.PubMedGoogle Scholar
  90. 90.
    von Känel R. Platelet hyperactivity in clinical depression and the beneficial effect of ­antidepressant drug treatment: how strong is the evidence? Acta Psychiatr Scand. 2004;110:163-177.CrossRefGoogle Scholar
  91. 91.
    Parakh K, Sakhuja A, Bhat U, Ziegelstein RC. Platelet function in patients with depression. South Med J. 2008;101:612-617.PubMedCrossRefGoogle Scholar
  92. 92.
    Musselman DL, Tomer A, Manatunga AK, et al. Exaggerated platelet reactivity in major depression. Am J Psychiatry. 1996;153:1313-1317.PubMedGoogle Scholar
  93. 93.
    Walsh MT, Dinan TG, Condren RM, et al. Depression is associated with an increase in the expression of the platelet adhesion receptor glycoprotein Ib. Life Sci. 2002;70:3155-3165.PubMedCrossRefGoogle Scholar
  94. 94.
    Morel-Kopp M-C, McLean L, Tofler GH, et al. The association of depression with platelet activation: evidence for a treatment effect. J Thromb Haemost. 2009;7:573-581.PubMedCrossRefGoogle Scholar
  95. 95.
    Pollock BG, Laghrissi-Thode F, Wagner WR. Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. J Clin Psychopharmacol. 2000;20:137-140.PubMedCrossRefGoogle Scholar
  96. 96.
    Laghrissi-Thode F, Wagner WR, Pollock BG, et al. Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry. 1997;42:290-295.PubMedCrossRefGoogle Scholar
  97. 97.
    Serebruany VL, Glassman AH, Malinin AI, Sertraline AntiDepressant Heart Attack Randomized Trial Study Group, et al. Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy. Circulation. 2003;108:939-944.PubMedCrossRefGoogle Scholar
  98. 98.
    van Zyl LT, Lespérance F, Frasure-Smith N, et al. Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study. J Thromb Thrombolysis. 2009;27:48-56.PubMedCrossRefGoogle Scholar
  99. 99.
    Folsom AR, Qamhieh HT, Flack JM, et al. Plasma fibrinogen: levels and correlates in young adults. The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Epidemiol. 1993;138:1023-1036.PubMedGoogle Scholar
  100. 100.
    Maes M, Delange J, Ranjan R, et al. Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiatry Res. 1997;66:1-11.PubMedCrossRefGoogle Scholar
  101. 101.
    Kop WJ, Gottdiener JS, Tangen CM, et al. Inflammation and coagulation factors in persons >65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol. 2002;89:419-424.PubMedCrossRefGoogle Scholar
  102. 102.
    Panagiotakos DB, Pitsavos C, Chrysohoou C, ATTICA study, et al. Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA study. Eur Heart J. 2004;25:492-499.PubMedCrossRefGoogle Scholar
  103. 103.
    Matthews KA, Schott LL, Bromberger J, et al. Associations between depressive symptoms and inflammatory/hemostatic markers in women during the menopausal transition. Psychosom Med. 2007;69:124-130.PubMedCrossRefGoogle Scholar
  104. 104.
    von Känel R, Bellingrath S, Kudielka BM. Association between longitudinal changes in depressive symptoms and plasma fibrinogen levels in school teachers. Psychophysiology. 2009;46:473-480.CrossRefGoogle Scholar
  105. 105.
    Lahlou-Laforet K, Alhenc-Gelas M, Pornin M, et al. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease. Am J Cardiol. 2006;97:1287-1291.PubMedCrossRefGoogle Scholar
  106. 106.
    Geiser F, Meier C, Wegener I, et al. Association between anxiety and factors of coagulation and fibrinolysis. Psychother Psychosom. 2008;77:377-383.PubMedCrossRefGoogle Scholar
  107. 107.
    von Känel R, Kudielka BM, Schulze R, et al. Hypercoagulability in working men and women with high levels of panic-like anxiety. Psychother Psychosom. 2004;73:353-360.CrossRefGoogle Scholar
  108. 108.
    Pitsavos C, Panagiotakos DB, Papageorgiou C, et al. Anxiety in relation to inflammation and coagulation markers, among healthy adults: the ATTICA study. Atherosclerosis. 2006;185:320-326.PubMedCrossRefGoogle Scholar
  109. 109.
    Zafar MU, Paz-Yepes M, Shimbo D, et al. Anxiety is a better predictor of platelet reactivity in coronary artery disease patients than depression. Eur Heart J. 2010;31:1573-1582.PubMedCrossRefGoogle Scholar
  110. 110.
    Appels A. Exhaustion and coronary heart disease: the history of a scientific quest. Patient Educ Couns. 2004;55:223-229.PubMedCrossRefGoogle Scholar
  111. 111.
    Kudielka BM, Bellingrath S, von Känel R. Circulating fibrinogen but not D-dimer level is associated with vital exhaustion in school teachers. Stress. 2008;11:250-258.PubMedCrossRefGoogle Scholar
  112. 112.
    Raikkonen K, Lassila R, Keltikangas-Jarvinen L, Hautanen A. Association of chronic stress with plasminogen activator inhibitor-1 in healthy middle-aged men. Arterioscler Thromb Vasc Biol. 1996;16:363-367.PubMedCrossRefGoogle Scholar
  113. 113.
    von Känel R, Frey K, Fischer J. Independent relation of vital exhaustion and inflammation to fibrinolysis in apparently healthy subjects. Scand Cardiovasc J. 2004;38:28-32.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2011

Authors and Affiliations

  1. 1.Department of Medicine, Solna, Clinical Pharmacology Unit, Karolinska InstituteKarolinska University Hospital/SolnaStockholmSweden
  2. 2.Department of General Internal Medicine, InselspitalBern University HospitalBernSwitzerland
  3. 3.Division of Psychosomatic Medicine, InselspitalBern University HospitalBernSwitzerland

Personalised recommendations